FSHD Radio Hot off the Press: Dr. Amy Halseth Answers Your Questions about Avidity’s FORTITUDE Trial

Have questions about Avidity’s upcoming FORTITUDE trial? This month, our Hot off the Press guest is Amy Halseth, PhD, of Avidity Biosciences. Amy is the Executive Director of Clinical Development and serves as the Program Lead for the company’s FSHD program. Avidity Biosciences has announced its plans to launch FORTITUDE, a Phase 1 / 2 clinical trial. Amy sat down Leigh Reynolds of the FSHD Society to answer your questions from last month’s webinar. You can watch the webinar here if you missed it: bit.ly/3nc9LPV

Catch our Hot off the Press episodes on the 4th Thursday of each month. Listen on your favorite podcast player or watch on YouTube. Subscribe to make sure you never miss an episode!